收藏切换
Preparation and in vitro and in vivo Activity of ADCC Enhanced Claudin18.2 Monoclonal Antibody
收藏切换
Zhongsong ZHU1, 2, Wei PENG1, 2, Zhong LIU3, Guimin ZHANG3, Lili ZHAO1, 2, *
Chinese Journal of Pharmaceuticals | 2025, 56(2) : 190 - 197
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2025, 56(2): 190-197
• Paper •
Preparation and in vitro and in vivo Activity of ADCC Enhanced Claudin18.2 Monoclonal Antibody
Full
Zhongsong ZHU1, 2, Wei PENG1, 2, Zhong LIU3, Guimin ZHANG3, Lili ZHAO1, 2, *
Affiliations
  • 1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
  • 2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400
  • 3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000
Published: 2025-02-10 doi: 10.16522/j.cnki.cjph.2025.02.007
Outline
收藏切换

The Claudin18.2 antibody holds significant potential in the treatment of gastric carcinoma. However, due to its non-human sequence and relatively weak receptor affinity, the efficacy and safety of the marketed antibodies still need to be improved. Through hybridoma screening, antibody humanization and modification of antibody-dependent cell-mediated cytotoxicity(ADCC), this study obtained the monoclonal antibody, named 110E2A4-M2, that specifically binds to Claudin18.2. Subsequently, the ADCC and complement-dependent cytotoxicity(CDC) activities of the antibody were determined, and its pharmacological effects were studied in a mouse xenograft tumor model. The results showed that the ADCC activity of 110E2A4-M2 was significantly higher than that of the control antibody(IMAB362), and its CDC activity was not reduced. It displayed a relatively strong tumor-suppressing ability in the mouse subcutaneous xenograft tumor model, with a tumor growth inhibition rate of 52.35%. This study provided data support for the development of Claudin18.2 antibodies.

gastric carcinoma  /  Claudin18.2 monoclonal antibody  /  hybridoma technique  /  antibody humanization  /  antibody-dependent cell-mediated cytotoxicity  /  gene engineering
朱中松, 彭伟, 刘忠, 张贵民, 赵丽丽. ADCC增强型Claudin18.2单克隆抗体的制备和体内外活性. 中国医药工业杂志, 2025 , 56 (2) : 190 -197 . DOI: 10.16522/j.cnki.cjph.2025.02.007
Zhongsong ZHU, Wei PENG, Zhong LIU, Guimin ZHANG, Lili ZHAO. Preparation and in vitro and in vivo Activity of ADCC Enhanced Claudin18.2 Monoclonal Antibody[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (2) : 190 -197 . DOI: 10.16522/j.cnki.cjph.2025.02.007
Year 2025 volume 56 Issue 2
31
8
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.02.007
  • Receive Date:2024-11-29
  • Online Date:2026-11-17
  • Published:2025-02-10
Article Data
Affiliations
History
  • Received:2024-11-29
Funding
Affiliations
    1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
    2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400
    3.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.02.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT